Fairbanks Building Connections to Potential Partners and Collaborators

Fairbanks was selected this year to participate at the NIH Innovation Conference (NIC) and Life Sciences Summit (LSS). These are exciting opportunities to pitch to mentors, investors and possible interested partners.

At the October 13 NIC, Fairbanks CEO Alan Schneyer presented the company via the video linked below, and industry mentors provided evaluations and feedback. The mentors expressed interest and provided some very positive comments like “The idea of converting alpha cells to beta cells is compelling!”

NIC is sponsored by SEED (Small business Education and Entrepreneurial Development) in the NIH Office of Extramural Research, and Fairbanks is very grateful to SEED for organizing the event and coordinating connections.

Next up is the Life Sciences Summit, November 17-18, sponsored by the Center for Biotechnology. At this event, Fairbanks will present as part of the Emerging Company Showcase. Event organizers say “Each company featured in the Emerging Company Showcase was nominated, reviewed and invited to present based upon their innovative science and the quality of their management team.”

This will be a valuable opportunity to connect with potential partners and collaborators, and the company is excited to be part of it.

Pitch video delivered to October 13, 2020 NIH Innovation Conference by Fairbanks Pharmaceuticals CEO Alan Schneyer